Novel Insights into the Interplay Between M6A Modification and Programmed Cell Death in Cancer

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2023 Apr 17

PMID 37063421

Authors

Jinhao Chen

Mujie Ye

Jianan Bai

Chunhua Hu

Feiyu Lu

DanYang Gu

Ping Yu

Qiyun Tang

Affiliations

Soon will be listed here.

Abstract

N6-methyladenosine (m6A) methylation, the most prevalent and abundant RNA modification in eukaryotes, has recently become a hot research topic. Several studies have indicated that m6A modification is dysregulated during the progression of multiple diseases, especially in cancer development. Programmed cell death (PCD) is an active and orderly method of cell death in the development of organisms, including apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis. As the study of PCD has become increasingly profound, accumulating evidence has revealed the mutual regulation of m6A modification and PCD, and their interaction can further influence the sensitivity of cancer treatment. In this review, we summarize the recent advances in m6A modification and PCD in terms of their interplay and potential mechanisms, as well as cancer therapeutic resistance. Our study provides promising insights and future directions for the examination and treatment of cancers.

Citing Articles

The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.

Wang H, Han J, Kong H, Ma C, Zhang X Biomolecules. 2025; 15(2).

PMID: 40001550 PMC: 11853213. DOI: 10.3390/biom15020247.

-induced promotes the malignant progression of pancreatic neuroendocrine neoplasms through -mediated lipid metabolism.

Chen J, Ye M, Gu D, Yu P, Xu L, Xue B Int J Biol Sci. 2025; 21(4):1478-1496.

PMID: 39990672 PMC: 11844274. DOI: 10.7150/ijbs.103428.

Pyroptosis and chemical classification of pyroptotic agents.

Hara M, Ramadan M, Abdelhameid M, Taher E, Mohamed K Mol Divers. 2024; .

PMID: 39316325 DOI: 10.1007/s11030-024-10987-6.

Predicting prognosis and drug sensitivity in bladder cancer: an insight into Pan-programmed cell death patterns regulated by M6A modifications.

Wang R, Li Z, Shen J Sci Rep. 2024; 14(1):18321.

PMID: 39112614 PMC: 11306778. DOI: 10.1038/s41598-024-68844-3.

Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.

Tang X, Guo M, Zhang Y, Lv J, Gu C, Yang Y J Exp Clin Cancer Res. 2024; 43(1):216.

PMID: 39095902 PMC: 11297759. DOI: 10.1186/s13046-024-03136-2.

References

Knuckles P, Lence T, Haussmann I, Jacob D, Kreim N, Carl S . Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the mA machinery component Wtap/Fl(2)d. Genes Dev. 2018; 32(5-6):415-429. PMC: 5900714. DOI: 10.1101/gad.309146.117. View

Dai X, Shi L, Li Z, Yang H, Wei J, Ding Q . Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers. Front Oncol. 2021; 11:635329. PMC: 8076607. DOI: 10.3389/fonc.2021.635329. View

Lederer M, Bley N, Schleifer C, Huttelmaier S . The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. Semin Cancer Biol. 2014; 29:3-12. DOI: 10.1016/j.semcancer.2014.07.006. View

Zheng J, Guo J, Wang Y, Zheng Y, Zhang K, Tong J . Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer. Front Mol Biosci. 2022; 8:735871. PMC: 8807408. DOI: 10.3389/fmolb.2021.735871. View

Jin D, Guo J, Wu Y, Du J, Yang L, Wang X . mA mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 2021; 14(1):32. PMC: 7901070. DOI: 10.1186/s13045-021-01048-8. View

Hsu S, Li C, Lin I, Syue W, Chen Y, Cheng K . Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021; 11(18):8813-8835. PMC: 8419056. DOI: 10.7150/thno.62521. View

Guo M, Yan R, Ji Q, Yao H, Sun M, Duan L . IFN regulatory Factor-1 induced macrophage pyroptosis by modulating m6A modification of circ_0029589 in patients with acute coronary syndrome. Int Immunopharmacol. 2020; 86:106800. DOI: 10.1016/j.intimp.2020.106800. View

Ueda Y, Ooshio I, Fusamae Y, Kitae K, Kawaguchi M, Jingushi K . AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep. 2017; 7:42271. PMC: 5304225. DOI: 10.1038/srep42271. View

Guo Z, Zhang X, Lin C, Huang Y, Zhong Y, Guo H . METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification. Front Oncol. 2022; 12:962204. PMC: 9582246. DOI: 10.3389/fonc.2022.962204. View

10.

Genuth N, Barna M . Heterogeneity and specialized functions of translation machinery: from genes to organisms. Nat Rev Genet. 2018; 19(7):431-452. PMC: 6813789. DOI: 10.1038/s41576-018-0008-z. View

11.

Liu L, Gu M, Ma J, Wang Y, Li M, Wang H . CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma. Mol Cancer. 2022; 21(1):149. PMC: 9297645. DOI: 10.1186/s12943-022-01619-4. View

12.

Zeng C, Huang W, Li Y, Weng H . Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020; 13(1):117. PMC: 7457244. DOI: 10.1186/s13045-020-00951-w. View

13.

Gao Y, Ouyang X, Zuo L, Xiao Y, Sun Y, Chang C . R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway. Mol Ther Oncolytics. 2021; 23:65-81. PMC: 8479483. DOI: 10.1016/j.omto.2021.06.017. View

14.

Dong L, Chen C, Zhang Y, Guo P, Wang Z, Li J . The loss of RNA N-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8 T cell dysfunction and tumor growth. Cancer Cell. 2021; 39(7):945-957.e10. DOI: 10.1016/j.ccell.2021.04.016. View

15.

Shi R, Ying S, Li Y, Zhu L, Wang X, Jin H . Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics. Cell Death Dis. 2021; 12(4):346. PMC: 8016981. DOI: 10.1038/s41419-021-03625-8. View

16.

Chen X, Gong W, Shao X, Shi T, Zhang L, Dong J . METTL3-mediated mA modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann Rheum Dis. 2021; 81(1):87-99. DOI: 10.1136/annrheumdis-2021-221091. View

17.

Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L . RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022; 7(1):334. PMC: 9499983. DOI: 10.1038/s41392-022-01175-9. View

18.

He Y, Yue H, Cheng Y, Ding Z, Xu Z, Lv C . ALKBH5-mediated mA demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling. Cell Death Dis. 2021; 12(12):1121. PMC: 8636648. DOI: 10.1038/s41419-021-04401-4. View

19.

Liu B, Tu Y, Ni G, Yan J, Yue L, Li Z . Total Flavones of Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent mA Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling. Front Pharmacol. 2021; 12:667644. PMC: 8319635. DOI: 10.3389/fphar.2021.667644. View

20.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View